At the single-cell level, our PAX7 target gene repression biomarker is a better discriminator of FSHD versus control cells, and can even discriminate DUX4 target gene-negative FSHD cells from controls. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.